novartis

Welcome to the 'novartis' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'novartis'.

Are you an expert about 'novartis'? Do you want to be the Technorati authority on 'novartis'? You can write a description that will appear right here: Join Blogcritics!

Latest blogosphere posts tagged “novartis”

 

• Big Pharma testing waters with mobile tech

  
  FierceBiotech IT — Authority: 411
  Developers of mobile technologies have made some inroads with deep-pocketed drugmakers, which have sought the help of new apps and devices to streamline the development, marketing and sales of meds. Tech and biopharma entrepreneurs are betting that Big Pharma has an appetite for more mobile innovations. With drug ...
  1 week ago

• Gilenya by Novartis is under review by European Medicines Agency

  
  All you want to know — Authority: 429
  The European Medicines Agency said to doctors on Friday to have a check on patients for six hours after giving them a first dose of Novartis AG’s Gilenya , a blockbuster product for multiple sclerosis from the company. The organization started reviewing the safety of the medicine after the reports of heart ...
  1 week ago

• Sandoz initiates two more Phase III biosimilar trials, reinforcing long-term global leadership commitment

  
  Pharmainfo.net — Authority: 150
  
  1 week ago

• Novartis meningitis B vaccine aces study en route to market

  
  FierceVaccines — Authority: 456
  The remaining type of meningitis for which no vaccine exists has finally met its match. In a study backed by Novartis ( $NVS ), researchers found the Swiss drug giants experimental vaccine, dubbed 4CMenB, provided an immune response in nearly 100% of the more than 1,600 adolescents studied, according to a ...
  1 week ago

• House Democrats Probe ADHD Drug Shortage

  
  Pharmalot — Authority: 582
  For much of the past year, various meds for attention deficit hyperactivity disorder have been in short supply. The lack of pills, such as Ritalin and Adderall XR, have caused a highly disruptive problem for children and their parents, much like the ongoing shortages of generic injectable medications have wreaked ...
  1 week ago

• Takeda Plans To Cut 2,800 Jobs In US & Europe

  
  Pharmalot — Authority: 582
  Three months after completing its $13 billion acquisition of Nycomed, Takeda Pharmaceuticals now plans to cut roughly 10 percent of its workforce, or 2,800 jobs - about 2,100 from Europe and 700 from the US - by 2016 in order to save approximately $2.6 billion. The reorganization will include closing an unspecified ...
  1 week ago

• Novartis receives approval for Lucentis® and launches Galvus® in China, two innovative therapies that support public health goals

  
  Pharmainfo.net — Authority: 150
  
  1 week ago

• Influenza, mamme italiane consapevoli dei rischi

  
  SALUTE DOMANI ? IL PORTALE DEL BENESSERE — Authority: 126
  E’ buona la consapevolezza delle mamme italiane dei rischi legati all’influenza: quasi la metà delle intervistate (46,5%) dichiara, infatti, che linfluenza è una patologia altamente trasmissibile e più del 60% identifica correttamente nei bambini di età inferiore ai 4 anni la fascia più colpita, mentre il 63% ...
  1 week ago

• Paula Deen Confirms Diabetes Diagnosis – VIDEO

  
  Hollywood Dame — Authority: 533
  Remember that rumor Paula Deen has type 2 diabetes and is going to replace her I HEART BUTTER Y’ALL bumper sticker with an I HEART NOVARTIS Y’ALL endorsement? Click HERE for a refresher. Turns out that the National Enquirer was right. Deen confirmed her diabetes diagnosis on the ‘ Today Show ’ with Al ...
  1 week ago

• Novartis Reverses Plant Closure In Switzerland

  
  Pharmalot — Authority: 582
  Nearly three months of sustained pressure has prompted Novartis to change its corporate mind and abandon plans to close a plant in Vaud, Switzerland, a step that will save about 320 jobs. At the same time, the drugmaker will elminate fewer than the 760 jobs that were originally to have been cut at a chemical plant in ...
  1 week ago

• Novartis’s Prangins site to remain open

  
  GenevaLunch — Authority: 429
  GenevaLunch.com NYON, SWITZERLAND – Novartis will not close its Prangin site and all jobs there will be saved, the company will be investing more money in the plant, canton Vaud will give the company a tax break and some of the unused space will be developed into housing. Tough talks between Novartis workers and ...
  1 week ago

• Pharmalot… Pharmalittle… Our 5th Birthday

  
  Pharmalot — Authority: 582
  Good morning, everyone, and how are you today? We hope the weekend was refreshing and relaxing. Now, though, the routine of meetings and deadlines has resumed. We would like to pause, however, to note that today marks our fifth birthday - five years ago today, we launched Pharmalot . And it has been quite a ride. We ...
  1 week ago

• Some queries on generic Exelon answered here

  
  College Debt Tips and Advice — Authority: 133
  Rivastigmine is a compound which is sold as a drug under the brand name of Exelon. The drug is basically a cholinergic agent. It is also referred to sometimes as a parasympathomimetic agent. The drug is basically put to use for the treatment of dementia in cases of Alzheimer’s disease and Parkinson’s disease. The ...
  1 week ago

• Lower Sales Unfortunately Equals Job Loss In US For One Pharmaceutical Company

  
  PharmaWatchDog — Authority: 113
  For one drug maker this year is not shaping up to be good so far.  Unfortunately according to news reports, Novartis is planning to cut jobs in anticipation of lower sales of 2 of their hypertension drugs. In all the Basel-based pharmaceutical giant Novartis AG said they are cutting 1,960 jobs. The Swiss company ...
  1 week ago

• Diabete: vildagliptin (Galvus®) approvato in Europa per i pazienti con diabete di tipo 2 e insufficienza renale

  
  SALUTE DOMANI ? IL PORTALE DEL BENESSERE — Authority: 126
  I pazienti diabetici con insufficienza renale moderata o grave hanno a disposizione una nuova opzione terapeutica: vildagliptin1, innovativa terapia orale che fa parte degli inibitori della DPP-4. L’approvazione della Commissione Europea estende l’impiego di vildagliptin, che era già indicato per i pazienti ...
  1 week ago

• FDA: Novartis plant shows patterns of problems

  
  — Authority:
  Health Canada on Friday advised Canadians that they should return certain Excedrin Extra Strength and Tension Headache caplets, just as drug giant Novartis ( $NVS ) advised U.S. consumers last week. According to a statement from Health Canada, the same issues underlie both recalls, and they resulted in chipped and ...
  2 weeks ago

• For Intrigue, Malaria Drug Artemisinin Gets the Prize

  
  NYT > Theater — Authority: 865
  LATE BLOOMER Sweet wormwood provides artemisinin, discovered decades ago in China.
  2 weeks ago

• Novartis to Layoff 1,960

  
  — Authority:
  T he Switzerland-based pharmaceutical company, Novartis, has announced cuts to their staff here in the US. The cuts are slated to be much larger in size than many had hoped, and a great number of them will affect workers in the state of New Jersey, though the layoffs are not confined to that state. The layoffs, ...
  2 weeks ago

• Vanessa McCutcheon Joins The Prestigious Ranks Of Stanford Who’s Who

  
  IBWIRE — Authority: 138
  SYDNEY, NSW, AUSTRALIA,   January 16, 2012 / Stanford Who’s Who / — Stanford Who’s Who proudly welcomes Vanessa McCutcheon to the exclusive ranks of premier professionals as a result of her phenomenal work in the pharmaceutical industry. Throughout her brilliant professional career, Vanessa has routinely ...
  2 weeks ago

• Novartis Registers 198 Domains With Latest Pill Recall

  
  DotWeekly.com Domain Name Blog — Authority: 107
  Novartis has announced a voluntary recall of several of its popular brands like Excedren®, Gas-X®, NoDoz® and Bufferen®. The recall was announced on January 9, 2012 but 3 days after the recall, Novartis went on a big domain name shopping spree and purchased 198 domain names related to the recalls. All the domain ...
  2 weeks ago

Comments about novartis